Murali Aravamudan

Murali Aravamudan

Founder and Chief Executive Officer (CEO)


Murali is a serial entrepreneur, inventor and engineer who built successful technology companies in the Media and Telecom ecosystems. He is the Founder of the Life Sciences venture nference, whose mission is to improve clinical outcomes and commercial decisions through a large scale Artificial Intelligence (AI) technology platform. He is also the Founding CEO of the Biotech company Qrativ, which was established as a Joint Venture between the Mayo Clinic and nference. Murali is a technology pioneer having authored 95 US patents and more than 100 pending patents in the areas of search, personalization, conversational interfaces, data networking, telephony and, more recently, computational biology, pharmaceutical drug discovery and molecular diagnostics.
 
Murali co-founded Veveo in 2004 with the goal of enabling quick and efficient content discovery in input constrained devices such as televisions and mobile phones. As CEO of Veveo, he established the company’s leadership in its target market segments with more than 100 million device deployments. Veveo was acquired by Rovi corporation (now TiVo) in 2014 for over $75M.
 
Prior to founding Veveo, Murali was Vice President and General Manager of the Winphoria Division of Motorola’s Global Telecom Solutions Sector, following the successful acquisition of Winphoria Networks, a company he founded in 2000 and led as CTO. Winphoria was a pioneer in the groundbreaking Mobile Wireless SoftSwitch and Instant Communications applications for mobile networks and was acquired by Motorola for around $200M.
 
Earlier in his career, Murali served as Vice President and Chief Technology Officer of the Communications Software Business at Lucent Technologies and as a department head of Communications Software Research at Bell Laboratories, Murray Hill.

View all team members →